Covid catalyses investment in biotech with 2022 set to be 'breakout' year

Tremendous potential, particularly in the spatial biology sector

clock • 4 min read

The pandemic has acted as a catalyst for the biotechnology and health industries, accelerating the pace at which new technologies are being adopted.

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Equities

Equity markets resilient amid 'uneasy' geopolitical events

Equity markets resilient amid 'uneasy' geopolitical events

Discipline important

Patrick Brusnahan
clock 23 April 2026 • 1 min read
Hargreaves Lansdown's Derren Nathan: A stellar year for the IPO watchlist

Hargreaves Lansdown's Derren Nathan: A stellar year for the IPO watchlist

Space, AI and banking

Derren Nathan
clock 17 April 2026 • 4 min read
McInroy & Wood's McNair and MacKinnon: Poor results do not always speak for themselves

McInroy & Wood's McNair and MacKinnon: Poor results do not always speak for themselves

'Stick to the process'

Jack McNair and Cameron MacKinnon
clock 16 April 2026 • 4 min read
Trustpilot